Nianzeng Xing
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Geriatrics and Gerontology top 2%
Papers in
-
- Renal cell carcinoma treatment 18
- Prostate Cancer Treatment and Research 14
- Prostate Cancer Diagnosis and Treatment 8
- Surgery 48
- Bladder and Urothelial Cancer Treatments 34
- Urinary and Genital Oncology Studies 13
- Co-authors
- Feiya Yang (59 shared papers)Matthew D. Griffin (4 shared papers)Rajiv Kumar (4 shared papers)Qinxin Zhao (15 shared papers)Xinxing Lu (6 shared papers)Mingshuai Wang (9 shared papers)Wenkuan Wang (8 shared papers)Hao Ping (13 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Frontiers in Oncology (5 papers)Advanced Materials (4 papers)BMC Urology (4 papers)Oncology Reports (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Nianzeng Xing
151 papers receiving 3.1k citations
Nianzeng Xing's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 445
- Geriatrics and Gerontology 95
- Biochemistry 176
- Pathology and Forensic Medicine 351
- Immunology 415
Countries citing papers authored by Nianzeng Xing
This map shows the geographic impact of Nianzeng Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianzeng Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianzeng Xing more than expected).
Fields of papers citing papers by Nianzeng Xing
This network shows the impact of papers produced by Nianzeng Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianzeng Xing. The network helps show where Nianzeng Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Nianzeng Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 357 | |
| 2 | Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy Hit paper breakdown → | 2023 | 313 |
| 3 | 2003 | 200 | |
| 4 | 2020 | 165 | |
| 5 | 2003 | 98 | |
| 6 | 2002 | 98 | |
| 7 | 2001 | 95 | |
| 8 | 2020 | 87 | |
| 9 | 2015 | 81 | |
| 10 | 2023 | 73 | |
| 11 | 2019 | 68 | |
| 12 | 2019 | 62 | |
| 13 | 2019 | 62 | |
| 14 | 2007 | 59 | |
| 15 | 2015 | 58 | |
| 16 | 2023 | 53 | |
| 17 | 2015 | 52 | |
| 18 | 2008 | 51 | |
| 19 | 2022 | 50 | |
| 20 | 2022 | 36 |
About Nianzeng Xing
Nianzeng Xing is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 159 papers that have together received 3.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (34 papers), Renal cell carcinoma treatment (18 papers), Prostate Cancer Treatment and Research (14 papers), Urinary and Genital Oncology Studies (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Urinary Bladder and Prostate Research (8 papers), Cancer, Lipids, and Metabolism (8 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Cancer Research (445 citations), Geriatrics and Gerontology (95 citations), Biochemistry (176 citations), Pathology and Forensic Medicine (351 citations) and Immunology (415 citations). Nianzeng Xing has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Feiya Yang, Matthew D. Griffin, Rajiv Kumar, Qinxin Zhao, Xinxing Lu, Mingshuai Wang, Wenkuan Wang, Hao Ping, Lu Yin and Sujun Han. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Advanced Materials, BMC Urology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.